TB-500 (Thymosin β4 fragment)

What Is TB-500? The Heptapeptide and Its Parent Protein

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-294 cited sources

The short answer

TB-500 (also written TB500 or TB 500) is a synthetic peptide based on the actin-binding region of thymosin beta-4. As normally supplied it is the N-acetylated heptapeptide Ac-LKKTETQ at 889.0 Da, not the 43-residue 4,963 Da parent protein, a distinction frequently lost, and a 5.6-fold difference in mass.

Key facts

TB-500 (as supplied)
Ac-LKKTETQ, 889.0 Da
Formula
C38H68N10O14
PubChem CID
62707662
Parent protein
Thymosin beta-4, 43 residues, 4,963 Da
Tβ4 CAS
77591-33-4 (the PARENT, not TB-500)
Motif
LKKTETQ, residues 17-23 of Tβ4
Status
Investigational; WADA-prohibited in sport

What TB-500 actually is

Thymosin beta-4 is a 43-residue protein whose actin-binding activity is concentrated in a short internal motif, LKKTETQ, at residues 17 to 23. TB-500 is that motif synthesised as a standalone peptide with an acetylated N-terminus. As supplied it is seven residues and 889.0 Da, which is a different molecule from the 4,963 Da protein it was derived from. It is supplied here on its own, as one of the three GLOW peptides, and as one of the four KLOW peptides.

The mass confusion, and how to settle it

TB-500's molecular weight is widely quoted as approximately 4.9 kDa. That figure belongs to full-length thymosin beta-4. The arithmetic settles which is which: unmodified LKKTETQ is 847.0 Da, TB-500 is 889.0 Da, and the 42.0 Da difference is exactly one acetyl group. Everything reconciles at the heptapeptide. Nothing reconciles at 4.9 kDa unless the material is the whole protein.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

The complication nobody states

What is sold as TB-500 is not consistent. Some material is the acetylated heptapeptide; some is full-length thymosin beta-4 sold under the TB-500 name. They differ by more than 4 kDa, have different CAS numbers, and are supported by different literatures. The actin-sequestration work applies to the motif, but much of the wound-repair and cardiac work used the full protein. Establishing which one a vial contains is not a formality.

Where the parent protein came from

Thymosin beta-4 was sequenced by Low and colleagues and published in the Proceedings of the National Academy of Sciences in February 1981, from bovine thymus, described at the time as a thymic hormone. Its actin-binding role was characterised later, and it is now understood primarily as the principal G-actin sequestering protein in many cell types rather than as a thymic hormone.

What the literature reports

Published work describes actin sequestration, effects on cell migration, angiogenesis in model systems, corneal wound healing in animal models and cardiac repair models. The evidence is overwhelmingly in vitro and animal, and a substantial share used full-length thymosin beta-4 rather than the heptapeptide.

Regulatory and sporting status

TB-500 holds no marketing authorisation from the MHRA, EMA or FDA. It is prohibited in sport under the World Anti-Doping Agency list, which is relevant to any research context involving competitive athletes. It is supplied here for laboratory research only.

Frequently asked questions

What is TB-500's molecular weight?

889.0 Da for the acetylated heptapeptide normally supplied. The widely quoted 4.9 kDa is full-length thymosin beta-4, a different molecule.

Is TB-500 the same as thymosin beta-4?

No. TB-500 is a seven-residue fragment of its actin-binding motif with an acetylated N-terminus. The parent protein is 43 residues.

Is CAS 77591-33-4 TB-500's CAS number?

No. That is thymosin beta-4's. TB-500 as the heptapeptide is a distinct compound, PubChem CID 62707662.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More TB-500 (Thymosin β4 fragment) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.